Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Severity of Chronic Kidney Disease and Outcomes After Admission to the Intensive Care Unit.

JAMA network open·2026
Same author

Phosphate-latest news and ongoing trials.

Clinical kidney journal·2026
Same author

2026 ISPD Position Statement on tracking and reporting loss from PD therapy.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026
Same author

Effects of Increasing the Concentration of Dialysate Magnesium on Cardiovascular Health: A Narrative Review.

Canadian journal of kidney health and disease·2026
Same author

Use of Peritoneal Dialysis for Delayed Graft Function After Kidney Transplantation: An International Survey.

Kidney360·2026
Same author

Systematic Review and Meta-Analysis of Intensive Care Unit Scoring Systems' Performance in Patients with Pre-Existing Kidney Disease.

Kidney international reports·2026
Same journal

Premature Aortic Stiffness in Relation to Cerebral Small Vessel Disease, Cognitive Decline, Major Cardiovascular Events and Mortality in Dialysis.

American journal of nephrology·2026
Same journal

Adjudicating heart failure as an end point in dialysis trials- more signal, less noise.

American journal of nephrology·2026
Same journal

Bridging the Evidence-to-Practice Gap in Hypertension: Why Innovation Isn't Always Implementation.

American journal of nephrology·2026
Same journal

Adjudicating Heart Failure Events in Participants Receiving Hemodialysis: Findings from Evaluation of Cinacalcet Hydrochloride Therapy to Lower Cardiovascular Events (EVOLVE) Trial.

American journal of nephrology·2026
Same journal

Beyond the Amount: The Selectivity of Proteinuria and Risk of Graft Failure in Kidney Transplant Recipients.

American journal of nephrology·2026
Same journal

Associations of body composition biomarkers with survival, cardiovascular events and progression in persons with chronic kidney disease: insights from Renal Risk in Derby Study.

American journal of nephrology·2026
See all related articles

Related Experiment Video

Updated: Apr 28, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.7K

Practical considerations when prescribing icodextrin: a narrative review.

Samuel A Silver1, Ziv Harel, Jeffrey Perl

  • 1Division of Nephrology, St. Michael's Hospital, University of Toronto, Toronto, Ont., Canada.

American Journal of Nephrology
|June 14, 2014
PubMed
Summary
This summary is machine-generated.

Icodextrin, a peritoneal dialysis solution, offers glucose-sparing benefits but requires careful management. Understanding its hemodynamic, metabolic, and idiopathic effects is crucial to prevent adverse events in patients undergoing peritoneal dialysis.

More Related Videos

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

33.8K
Transport Properties of Ibuprofen Encapsulated in Cyclodextrin Nanosponge Hydrogels: A Proton HR-MAS NMR Spectroscopy Study
10:10

Transport Properties of Ibuprofen Encapsulated in Cyclodextrin Nanosponge Hydrogels: A Proton HR-MAS NMR Spectroscopy Study

Published on: August 15, 2016

9.2K

Related Experiment Videos

Last Updated: Apr 28, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.7K
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

33.8K
Transport Properties of Ibuprofen Encapsulated in Cyclodextrin Nanosponge Hydrogels: A Proton HR-MAS NMR Spectroscopy Study
10:10

Transport Properties of Ibuprofen Encapsulated in Cyclodextrin Nanosponge Hydrogels: A Proton HR-MAS NMR Spectroscopy Study

Published on: August 15, 2016

9.2K

Area of Science:

  • Nephrology
  • Biochemistry

Background:

  • Icodextrin is a widely used peritoneal dialysis solution for enhanced ultrafiltration and preserving peritoneal membrane function.
  • Its glucose-sparing property is a key clinical advantage over dextrose-based solutions.
  • Healthcare providers need to be aware of icodextrin's unique properties due to its increasing clinical use.

Purpose of the Study:

  • To review the hemodynamic, metabolic, and idiopathic effects of icodextrin.
  • To provide guidance for the safe and effective prescription of icodextrin in peritoneal dialysis.
  • To minimize potential adverse events associated with icodextrin use.

Main Methods:

  • This study is a narrative review of existing literature on icodextrin.
  • It synthesizes information regarding the clinical considerations and effects of icodextrin.
  • The review focuses on adverse events and best practices for its application.

Main Results:

  • Hemodynamic effects can include hypotension due to increased ultrafiltration, potentially impacting residual kidney function.
  • Metabolic effects involve interference with biochemical assays, leading to inaccurate glucose readings on non-specific glucometers.
  • Idiopathic adverse effects encompass diffuse rash and sterile peritonitis; antibiotic stability in icodextrin also requires consideration.

Conclusions:

  • Failure to recognize icodextrin's specific properties can lead to patient harm.
  • Understanding these effects is essential for healthcare providers to confidently prescribe icodextrin.
  • Optimizing icodextrin use maximizes its benefits for patients on peritoneal dialysis.